Authors/Disclosures
|
Suzanne J. Hodgkinson, MD, MBBS, PhD, FRACP
|
The institution of Dr. Hodgkinson has received research support from MERCK. The institution of Dr. Hodgkinson has received research support from Atara. The institution of Dr. Hodgkinson has received research support from Biogen . The institution of Dr. Hodgkinson has received research support from Genzyme. The institution of Dr. Hodgkinson has received research support from ROCHE. The institution of Dr. Hodgkinson has received research support from Novartis. |
|
Ernest W. Willoughby, MD, MB
|
Dr. Willoughby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Merck and Roche. Dr. Willoughby has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Willoughby has received personal compensation in the range of $500-$4,999 for serving as a Chair of MS Treatment Assessment Committee with New Zealand Government Pharmaceutical Management Agency. Dr. Willoughby has a non-compensated relationship as a Patron / Medical Advisor with Auckland MS Society that is relevant to AAN interests or activities. |
|
Leslie Sedal, MBBS, FRACP
|
No disclosure on file |
|
Mark A. Paine, MD, MBBS, FRACP
(Alexandra Neurology)
|
No disclosure on file |
|
Helmut Butzkueven, MD, MBBS
|
Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis. |
|
Stan J. Siejka, MBBS
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Kathleen M. Curnow, PhD
(Biogen International GmBH)
|
No disclosure on file |
|
Atsushi Iwata, MD
(Tokyo Metropolitan Institute for Geriatrics and Gerontology)
|
No disclosure on file |